Geron Corporation

11/05/2024 | Press release | Distributed by Public on 11/05/2024 08:02

Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies